Lupin's Nanomi Subsidiary Update on Multicare Pharmaceuticals Philippines Acquisition
Lupin Limited has provided an update regarding the acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. The transaction involves Nanomi B.V., the Netherlands, which is a wholly owned subsidiary of Lupin Limited.The company previously informed stakeholders of the definitive agreements for Nanomi B.V. to acquire the minority shareholding from certain existing shareholders of Multicare Pharmaceuticals Philippines, Inc., a subsidiary of Nanomi.
In the initial update, the transaction was expected to be completed by the end of May 2026.
Lupin Limited announced that the proposed acquisition transaction is still in progress. The updated timeline suggests that the deal is now expected to be completed in July 2026, pending fulfillment of specific closing conditions.
LUPIN Stock Price Movement
Lupin Limited shares today slipped by 0.06% to settle at ₹2267.7. The stock recorded a traded volume of 2.94 million shares during post-market activity.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.